Cell Culture

3D Cell Clearing Market Soars Toward $171 Million
Biotech & Bioprocessing 3D Cell Clearing Market Soars Toward $171 Million

For decades, the intricate inner workings of biological tissues have remained largely hidden, with traditional microscopy methods only able to offer two-dimensional glimpses or superficial views of complex three-dimensional structures. This limitation has created a significant bottleneck in

Scientists Grow Meat on Scaffolds Made From Beer Waste
Biotech & Bioprocessing Scientists Grow Meat on Scaffolds Made From Beer Waste

A significant obstacle preventing cultivated meat from becoming a staple in grocery stores has been the challenge of creating affordable, complex structures that mimic the texture and composition of traditional cuts like steak or chops. Researchers at University College London have unveiled a novel

New Alliance to Advance AI in Cancer Genomics
Biotech & Bioprocessing New Alliance to Advance AI in Cancer Genomics

Within the intricate code of a patient's DNA lies both the blueprint of their cancer and the potential map to its defeat, yet unlocking these secrets has become a monumental challenge of information overload. The era of precision medicine has generated an ocean of genomic data, but navigating it to

Fujifilm Rebrands in a Major Life Sciences Push
Biotech & Bioprocessing Fujifilm Rebrands in a Major Life Sciences Push

A company once synonymous with capturing cherished family memories through photographic film is now engineering the very building blocks of life-saving medicines, marking one of the most significant corporate transformations in recent history. The name Fujifilm, long associated with vibrant color

Why Did a Promising Bone Drug Fail Its Final Test?
Research & Development Why Did a Promising Bone Drug Fail Its Final Test?

The journey of a new drug from laboratory concept to patient bedside is often paved with paradoxes, but rarely is the contradiction as stark as a medicine that successfully builds bone yet fails to stop it from breaking. This was the surprising outcome for setrusumab, a highly anticipated treatment

Biopharma Builds Resilient Networks for New Therapies
Biotech & Bioprocessing Biopharma Builds Resilient Networks for New Therapies

The successful journey of a life-saving gene therapy from a state-of-the-art laboratory to a patient's bedside now hinges less on its scientific brilliance and more on the sheer resilience of the global network tasked with its production. In a world defined by volatility, the biopharmaceutical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later